Supported in part by a Crohn's and Colitis Foundation of America Career Development Award (to M.A.C.), National Institutes of Health Grants DK075713 (to W.F.S.), DK089016, and L30-RR030244 (to M.A.C.), and P30-DK52574 (Washington University Digestive Diseases Research Core). N.K.G. was the recipient of a WUSM Dept of Internal Medicine Mentors in Medicine grant. A.I.T. was a Howard Hughes Medical Institute Medical Research Training Fellow.
Serum analysis of tryptophan catabolism pathway: Correlation with Crohn's disease activity†
Article first published online: 5 AUG 2011
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 7, pages 1214–1220, July 2012
How to Cite
Gupta, N. K., Thaker, A. I., Kanuri, N., Riehl, T. E., Rowley, C. W., Stenson, W. F. and Ciorba, M. A. (2012), Serum analysis of tryptophan catabolism pathway: Correlation with Crohn's disease activity. Inflamm Bowel Dis, 18: 1214–1220. doi: 10.1002/ibd.21849
- Issue published online: 11 JUN 2012
- Article first published online: 5 AUG 2011
- Manuscript Received: 12 JUL 2011
- Manuscript Accepted: 12 JUL 2011
Additional Supporting Information may be found in the online version of this article.
|IBD_21849_sm_SuppFig1.eps||60K||Supporting Information Figure 1. Linear regression plots for Tryptophan and Kynurenine assay by HPLC. Graphs show standards based plots for L-kynurenine and L-tryptophan spanning a concentration range of over 2 orders of magnitude shown in complete (left) and with an expanded lower dose range (right). Best fit slope: Tryptophan (43,774); Kynurenine (36,123).|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.